![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 48, 44841-44847, November 30, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, August 8, 2001, and in revised form, October 1, 2001
p50, a member of the Y-box binding transcription
factor family, is tightly associated with eukaryotic mRNAs and is
responsible for general translational regulation. Here we show that
p50, in addition to its previously described ability to melt mRNA
secondary structure, is capable of promoting rapid annealing of
complementary nucleic acid strands. p50 accelerates annealing of RNA
and DNA duplexes up to 1500-fold within a wide range of salt
concentrations and temperatures. Phosphorylation of p50 selectively
inhibits DNA annealing. Moreover, p50 catalyzes strand exchange between double-stranded and single-stranded RNAs yielding a product
bearing a more extended double-stranded structure. Strikingly, p50
displays both RNA-melting and -annealing activities in a
dose-dependent manner; a relatively low amount of p50
promotes formation of RNA duplexes, whereas an excess of p50 causes
unwinding of double-stranded forms. Our results suggest that the
alteration of nucleic acid conformation is a basic mechanism of the
p50-dependent regulation of gene expression.
Over the past decade, an increasing number of multifunctional
proteins have been described that are involved in regulation of gene
expression at both transcriptional and post-transcriptional levels
(1-4). For example, proteins of the Y-box family, originally discovered in connection with their ability to bind to the Y-box promoter element, play an important role in transcriptional regulation of a wide variety of genes, in DNA repair and replication as well as in
the regulation of mRNA translation, storage, and localization (5-8). These proteins represent a highly conserved group of nucleic acid-binding proteins present in bacteria, plants, and animals (9, 10).
The fact that such a diversity of biological functions is displayed by
closely related or even identical Y-box proteins (~98% amino acid
identity between rabbit p50 and EF1A/dbpB/YB-1 from
chicken, rat, and human) suggests similar mechanisms of their action.
Studies to date indicate that Y-box proteins may prevent nucleic acid
secondary structure formation by a mechanism that is not well
understood (11-15).
p50 was described initially as the major core protein of messenger
ribonucleoprotein particles
(mRNPs)1 in somatic cells
(11, 16-18). It is a predominant component of inactive free globin
mRNPs. p50 content in free mRNPs is approximately 2-fold higher than
that in active polysomal mRNPs (8, 19). Consistent with these data, low
levels of p50 (~10 molecules/globin mRNA) stimulate translation
initiation in vitro, whereas doubling of p50 amounts (~20
molecules/globin mRNA) results in complete inhibition of protein
synthesis (18, 20-22). Several lines of evidence indicate that p50 is
a major general translation regulator through mRNA structural
arrangements and packaging (6, 8, 14, 23). First, it is found in
association with a wide range of mRNAs and displays little or no
sequence-specificity. Second, it possesses the strongest affinity for
mRNA as compared with other mRNA-binding proteins. Third, it is
capable of self-oligomerization, suggesting possible mRNA packaging
when p50 is present in mRNPs in high copies. Finally, p50 was
demonstrated to efficiently melt mRNA secondary structure (11).
Here, we report that p50 is able to promote the rapid annealing of
complementary RNA and DNA strands and to catalyze the strand exchange
between ds- and ssRNAs yielding a product with a more extended ds
structure. Interestingly, the DNA annealing activity can be regulated
specifically by phosphorylation of p50 by casein kinase II. Based on
these results, we propose that members of the Y-box family regulate
gene expression at the transcription and translational level because of
their ability to modulate RNA and DNA secondary structure.
Materials--
Restriction enzymes, RNasin, Fermentas (Vilnius)
and T7 RNA polymerase used in this study were obtained from MBI.
T4 polynucleotide kinase and casein kinase II were purchased from New
England BioLabs. Proteinase K, NTPs, and dNTPs were from Roche
Molecular Biochemicals. [ p50 Purification and Phosphorylation--
Rabbit
recombinant p50 was expressed in Escherichia coli BL21(DE3)
and purified as described previously (22, 24). p50 was stored in buffer
containing 10 mM Hepes-KOH, pH 7.6, 100 mM KCl
at Preparation of RNA and DNA Substrates--
ssRNAs were produced
by in vitro transcription from the T7 promoter of the
appropriately linearized pSP72 and pSP73 vectors containing the same
linker region in opposite orientations. Briefly, the partially
complementary 58- and 69-nt ssRNAs capable of forming the 18-bp
heteroduplex were transcribed from BamHI-linearized pSP73
and PstI-linearized pSP72, respectively. 97- and 98-nt
ssRNAs bearing the 85-nt complementary region were synthesized from
BglII-linearized pSP73 and XhoI-linearized pSP72,
respectively. To generate dsRNAs, these two pairs of partially
complementary ssRNAs were incubated in 30 mM PIPES, pH 6.8, 1 mM EDTA at 100 °C for 5 min and slowly cooled down to
20 °C. To monitor the reaction efficiency, one ssRNA of each pair
was uniformly labeled with [
Complementary DNA strands used in DNA annealing reactions were obtained
by polymerase chain reaction amplification of pBluescript SK( Assay--
For RNA annealing, each ssRNA pair was mixed with
increasing amounts of p50 as indicated in the figure legends. The
reaction mixture (10 µl) containing 20 mM Hepes-KOH, pH
7.6, 50 mM KCl, and 0.2 units/µl RNasin) was incubated at
30 °C for 20 min (unless stated otherwise). The reaction was stopped
by the addition of 10 µg proteinase K, 0.1% SDS followed by
incubation for an additional 5 min and then by phenol-chloroform
extraction. Reaction products were separated by 5% SDS-polyacrylamide
gel electrophoresis (29:1 acrylamide:bisacrylamide) in 0.5× Tris
borate-EDTA at 25 mA for 2 h and visualized by autoradiography.
RNA strand exchange activity of p50 was analyzed as described above
using an annealed product of nonlabeled 69-nt RNA and 32P-labeled 58-nt RNA (containing 18-bp-long duplex), and
97-nt ssRNA possessing a 46-nt region complementary to the labeled
strand of the duplex. The mixture was incubated at 37 °C for 30 min.
DNA annealing activity of p50 was analyzed as described above using the
heat-denatured 5'-end-labeled 164-mer DNA. The DNA products were
separated on 8% SDS-polyacrylamide gel and visualized by
autoradiography. Quantification of the relative amounts of ss- and
dsRNA/DNA was done using the Kodak Digital 1D Program.
p50 Exhibits RNA Strand Annealing Activity--
RNA annealing
activity was reported earlier for several proteins implicated in
structural organization of heterogeneous nuclear RNA (25-29). To test
whether p50 exhibits RNA annealing activity, we incubated two pairs of
ssRNAs (58/69-nt and 97/98-nt long) with p50 (see "Experimental
Procedures"). In both cases, the addition of increasing amounts of
p50 resulted in a gradual decrease of ss-form content (Fig. 1,
A and B,
lanes 1-6). This was accompanied by the appearance of a
predominant slowly migrating band corresponding to a duplex-containing
form, which can be obtained by a standard annealing of the ssRNAs in
the absence of p50 (Fig. 1, A and B, lane
7). Interestingly, the p50 annealing efficiency in the two cases
was different: annealing of a pair of smaller RNAs with a short (18-nt)
complementary region was completed at p50/RNA molar ratios of ~10;
whereas complete annealing of longer RNAs with a longer (85-nt)
complementary region was achieved at p50/RNA molar ratios of ~6
(p50/nucleotide ratios of 1:7 and 1:17, respectively). Because the p50
binding efficiency is similar for all four of ssRNAs used (data not
shown), we conclude that extension of the complementary region
facilitates p50 RNA annealing efficiency.
To optimize annealing conditions, RNA duplex formation was analyzed at
various salt concentrations and temperatures. As seen in Fig.
2A, the ability of p50 to
anneal RNA is strongly dependent on the incubation temperature;
~4-fold more p50 was required for complete annealing at 20 °C than
at 37 °C. The p50 RNA annealing ability was similar at KCl
concentrations from 50 to 200 mM but clearly decreased at
400 mM KCl (Fig. 2B). As expected, ATP had no
effect on the reaction (data not shown), because p50 possesses no
ATPase activity.2
Physiological Mg2+ concentration (1 mM) does
not affect p50 annealing efficiency; however, high Mg2+
concentration (9 mM) caused considerable RNA aggregation in
the presence of p50 (Fig. 2C).
The rate of annealing was strongly dependent on the p50 concentration
in the reaction mixture; a 2-fold rise in p50 concentration resulted in
a decrease of a half-annealing time from the initial 20 min to 3 min
(Fig. 2, D and E). In contrast, the efficiency of
self-annealing of the RNAs in the absence of p50 was lower than 50%
over the 24-h incubation period (data not shown). Thus, p50 accelerates
RNA strand annealing up to 1000-fold in a
concentration-dependent manner within a wide range of salt
concentrations and temperatures.
Stimulation of DNA Annealing by p50--
Because p50 is able to
bind a broad spectrum of DNAs (8, 11), it was interesting to determine
whether p50 promotes DNA annealing as well. For this purpose,
complementary 164-nt-long single-stranded DNAs were obtained by heat
denaturation of a labeled polymerase chain reaction product (see
"Experimental Procedures"; Fig. 3,
A and B). It is
important to note that complete renaturation of DNA was achieved at the
p50/ssDNA molar ratio of ~600 (p50/nucleotide ratio of 3.5), which is
significantly higher than required for RNA annealing. This difference
is probably because of a lower affinity of p50 for DNA than for
RNA.3 The rate of
p50-promoted DNA annealing was not affected significantly by the
addition of ATP/Mg2+ by or changes in ionic strength
(0-100 mM KCl) (data not shown). Remarkably, in the
presence of 22 pmol of p50 at 30 °C, the half-time of DNA
renaturation was 5 min, whereas without p50 this value was higher than
120 h (Fig. 3, C and D). Thus, p50
accelerates DNA annealing up to 1500-fold.
p50 Displays Both RNA Annealing and Melting Activities in a
Dose-dependent Manner--
The RNA annealing activity of
p50 is surprising in the light of previous findings that high p50/RNA
ratios cause RNA melting (11). Therefore, we hypothesized that p50 can
display either annealing or melting activity depending on the p50/RNA
ratio. To test this assumption, a 69-nt RNA with predicted 55%
intrastrand complementarity was used. The mobility of this native form
appeared to be lower than that of the same RNA after heat denaturation (Fig. 4, lanes 1 and
6). Upon the addition of increasing amounts of p50, native
RNA was converted almost completely to a faster migrating, denatured
form (compare lanes 2-4 with 5 and
6). Alternatively, the addition of 11 pmol of p50 to the
heat-denatured RNA resulted in its complete renaturation (compare
lanes 6 and 7 with 8 and 9). Upon a further 2-fold increase of p50, the renatured
natively behaving RNA was partially converted back into its denatured
form as expected (lane 10). These results strongly suggest
that p50 can shift the equilibrium between ss- and dsRNA forms
either way in a dose-dependent manner.
p50 Exhibits RNA Strand Exchange Activity and Promotes the
Formation of the Most Extended Duplex--
Because p50 promotes
transitions between ss- and dsRNAs, we tested p50 for RNA strand
exchange activity. Such an activity, reported earlier (30-32)
for several proteins possessing nucleic acid strand-annealing
properties, results in the replacement of one strand in the RNA duplex
with a new strand, yielding a more extended duplex. We tested the
ability of p50 to facilitate the exchange of one strand in an 18-bp
duplex-containing RNA for another one, a 97-nt strand that yields a
46-bp duplex (Fig. 5). The formation of a
new 46-bp product was monitored by the appearance of a new band with a
lower electrophoretic mobility. As seen in Fig. 5, p50 efficiently
catalyzed RNA strand exchange and promoted the formation of the 46-bp
duplex RNA (compare lanes 1 and 2-8). It is
important to note that p50 induced only formation of a more extended
duplex structure (the reverse reaction did not occur; results
not shown), suggesting that the RNA strand exchange reaction is
thermodynamically driven by complementary base-pairing.
Effect of p50 Phosphorylation on Its RNA and DNA Annealing
Activities--
p50 and other Y-box proteins readily undergo
phosphorylation by casein kinase II in a variety of cells (18, 33, 34). To test the effect of p50 phosphorylation by casein kinase II on its
ability to accelerate RNA and DNA annealing, p50 was exhaustively phosphorylated in vitro by casein kinase II (2.6 mol of
phosphate/mol of p50).3 Surprisingly, the phosphorylation
of p50 produced no effect on RNA annealing (Fig.
6A), although it notably
inhibited DNA annealing (Fig. 6B). Indeed, the addition of
22 pmol of nonphosphorylated p50 caused complete DNA annealing, whereas
the same amount of phosphorylated p50 resulted in annealing of only
~one-third of the initial ssDNA. These results indicate that
phosphorylation by casein kinase II may play a role in the
p50-dependent pathway of regulation of DNA
conformation.
In this paper we demonstrate that p50, a general
component of mRNPs in mammalian cells, promotes annealing of the
complementary RNA strands and accelerates strand exchange between the
partially complementary RNAs, resulting in the formation of more
extended duplexes. The effect of p50 is sequence-nonspecific. p50
accelerates RNA annealing up to 1000-fold; this finding suggests that
p50 could probably mediate the formation of specific mRNA
structures in response to intracellular stimuli. The striking finding
that p50 displays both RNA annealing and melting activities in a
dose-dependent manner can be of physiological significance.
As it was shown earlier, p50 causes opposite effects on mRNA
translatability depending on the p50/mRNA ratio (see the
Introduction). According to our new findings, this effect could be
explained by different conformational states of mRNA within
mRNP determined by the amount of p50 bound.
p50 is a major and universal component of cytoplasmic mRNPs; therefore,
it may play a key role in the mRNA spatial organization and general
regulation of translation through structural adjustments of mRNAs.
In this connection, it would be of interest to analyze in more detail
whether the amount of mRNA-associated p50 correlates with
translational regulation during stresses and during the cell cycle. It
is currently known that the amount of Y-box proteins increases
significantly in cancer cells (35, 36), and the amount of their
mRNAs increases manyfold during liver regeneration and cell growth
stimulation with serum or interleukins (37-39). The stresses (drugs,
UV) result in a redistribution of Y-box proteins between the nucleus
and the cytoplasm with an increase of their amount in the nucleus and a
decrease in the cytoplasm (40, 41).
p50 shares functional properties with the major proteins of
heterogeneous nuclear RNPs (hnRNPs), hnRNP A1, C1, and U, all of which
exhibit RNA annealing activity (26, 29). Although there is no apparent
sequence homology between these proteins and p50, they possess similar
modular organizations comprising related RNA-binding domains with RNP
1/RNP 2 recognition motifs and auxiliary arginine/glycine-rich
C-terminal domains (15, 42, 43). hnRNP proteins as well as p50 are able
to form large protein particles and arrange RNA on their surfaces (44).
For hnRNP A1 it was shown that the RNA-binding domains display RNA melting activity (45, 46). Most probably, the cold shock domain of p50
is responsible for the RNA melting activity, because the major cold
shock protein of E. coli (Csp A), which exhibits 43% identity to p50 cold shock domain, displays the same activity (12).
Also, Y-box proteins were found within hnRNPs (7), and their
involvement in processing of pre-mRNA was demonstrated (47). Thus,
all of these functionally related proteins accompany mRNA at all
stages of its biogenesis and seem to contribute to the appropriate
packaging of mRNA in the nucleus and the cytoplasm.
The ability of p50 to accelerate the renaturation of DNA complementary
strands (Fig. 3) is of a considerable interest. Because Y-box proteins
exhibit broad specificity in binding to single-stranded DNA sequences
(38, 48, 49), we used a plasmid polylinker DNA for our study.
Strikingly, p50 shortens the half-time of DNA-renaturation from
120 h to 5 min. Assuming that p50 operates also as a transcription regulator, it is likely that its interaction with different promoter elements induces significant rearrangements of DNA structure, thereby determining the transcription efficiency (50). In
addition, the DNA annealing activity may be important for DNA repair
and/or recombination (51-54). Indeed, increasing evidence indicates
that p50 (YB-1) is involved in DNA repair as well as in cell adaptation to therapeutic agents and UV irradiation (35, 40, 48). Of interest is
our finding that the DNA annealing activity of p50 can be specifically
regulated by casein kinase II phosphorylation (Fig. 6).
Although the detailed mechanism of annealing remains to be elucidated,
it is obvious that p50 and functionally similar proteins accelerate
RNA/DNA folding and formation of more stable duplexes (extended and
containing less mismatches). The relatively high p50/RNA ratios
required for annealing suggest that p50 works in a stoichiometric
rather than a catalytic manner. A similar conclusion has been drawn for
other proteins displaying annealing activity (55, 56). It was proposed
that these proteins induce melting of the interfering secondary
structure, thereby enhancing correct thermodynamically driven
intermolecular base-pairing (29, 57). In addition, because of
protein-protein interactions, the complementary strands of nucleic
acids can be brought in close proximity, thereby accelerating
the initial rate-limiting step of the annealing reaction (29).
Actually, many proteins displaying annealing activity exhibit a melting
activity as well (45, 58, 59). In addition, they contain clusters of
positively charged amino acid residues in their auxiliary domains,
which seem to be important for annealing. The replacement or removal of
only a few arginine residues from these clusters caused a drastic
decrease in the annealing activities as reported for the splicing
factor U2AF65 (60), nucleocapsid protein NCp7 from HIV-1
(61, 62), and NCp10 of Moloney murine leukemia virus (63, 64). These
positively charged clusters are believed to be important for shielding
negative charges of sugar-phosphate backbones of nucleic acid strands
during annealing. The domains responsible for the annealing and melting activities of p50 are still to be determined.
We thank Lucia Rothman-Denes and Elena
Davydova from the University of Chicago for helpful comments and
suggestions on the manuscript. We also thank K. Vasilenko for fruitful
discussions and A. Kommer and E. Serebrova for help in manuscript preparation.
*
This work was supported by the Russian Academy of Sciences
and Grants N 97-open-501 (to A. A. M. T. and L. P. O.) from
INTAS (International Association for the promotion of co-operation with scientists from the New Independent States of the former Soviet Union)
and N 00-15-9790 (to L. P. O.) from the Russian Foundation for Basic
Research.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Recipient of a Human Frontier Science Program Organization
long-term fellowship. Present address: Dept. of Biochemistry and McGill
Cancer Center, McGill University, 3655 Promenade Sir William Osler,
Montreal, Quebec H3G 1Y6, Canada.
Published, JBC Papers in Press, October 3, 2001, DOI 10.1074/jbc.M107581200
2
V. M. Evdokimova and M. A. Skabkin,
unpublished data.
3
M. A. Skabkin, V. A. Ustinov, V. M. Evdokimova, J. W. B. Hershey, and L. P. Ovchinnikov,
manuscript in preparation.
The abbreviations used are:
mRNP, messenger
ribonucleoprotein particle;
hnRNP, heterogeneous nuclear
ribonucleoprotein particle;
ssRNA, single-stranded RNA;
ssDNA, single-stranded DNA;
dsRNA, double-stranded RNA;
dsDNA, double-stranded DNA;
nt, nucleotide;
bp, base pair(s);
PIPES, 1,4-piperazinediethanesulfonic acid;
TBE, Tris-borate.
The Major Messenger Ribonucleoprotein Particle Protein p50 (YB-1)
Promotes Nucleic Acid Strand Annealing*
,
§,
Institute of Protein Research, Russian
Academy of Sciences, Pushchino, Moscow Region 142290, Russia and
the ¶ Department of Developmental Biology, Utrecht University,
Padualaan 8, 3584 CH Utrecht, The Netherlands
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-32P]UTP (2000 Ci/mmol) and
[
-32P]ATP (5000 Ci/mmol) were from Radioisotop
(Moscow). pSP72 and pSP73 vectors were obtained from Promega, and
pBluescript II SK(
) was from Stratagene.
70 °C. Protein concentration was determined by staining with a
Micro-BCA kit (Pierce). Phosphorylation of p50 (20 µg, 0.6 nmol) was
performed in a 40-µl reaction mixture containing 10 mM
Hepes-KOH, pH 7.6, 5 mM MgCl2, 100 mM KCl, 2 mM dithiothreitol, 2% glycerol, 1 mM ATP using 200 units of CKII. The reaction mixture was
incubated for 40 min at 30 °C, stopped by the addition of EDTA to 5 mM, and dialyzed against 10 mM Hepes-KOH, pH
7.6, 100 mM KCl.
-32P]UTP upon synthesis.
)
polylinker region using T3 and T7 universal primers. The 164-bp
polymerase chain reaction product was gel-purified with JetSorb
(Genomed), and both strands were 5'-end-labeled using [
-32P]ATP and T4 polynucleotide kinase. To obtain
ssDNAs, 164-bp DNA was denatured in H2O at 100 °C for 5 min and then rapidly chilled on ice.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (26K):
[in a new window]
Fig. 1.
p50 displays strong RNA annealing
activity. Upper panels, schematic representation of the
RNA annealing assay. A, annealing of the 18-bp RNA duplex.
32P-labeled 58-nt RNA (0.5 pmol) and 69-nt RNA (0.7 pmol)
were incubated at 30 °C for 20 min with 0, 1.4, 2.8, 5.5, 11, and 22 pmol of p50 (lanes 1-6). Lane 7, duplex RNA
obtained by hybridization of the corresponding ssRNAs in the absence of
p50; lane 8, 32P-labeled 58-nt RNA alone was
incubated in the presence of 22 pmol p50. B, annealing of
the 85-bp RNA duplex. 32P-labeled 97-nt RNA (0.3 pmol) and
98-nt RNA (0.5 pmol) were incubated at 30 °C for 20 min with 0, 0.28, 0.57, 1.1, 2.2, or 4.5 pmol of p50 (lanes 1-6).
Lane 7, duplex RNA obtained by hybridization of the
corresponding RNA strands in the absence of p50. The positions of ss-
and duplex-containing RNAs are indicated; the stars mark the
32P-labeled strand.

View larger version (37K):
[in a new window]
Fig. 2.
The effect of temperature, salt condition,
and p50/RNA stoichiometry on RNA annealing. A,
32P-labeled 58-nt RNA (0.5 pmol) and 69-nt RNA (0.7 pmol)
possessing the 18-bp complementary region were incubated for 20 min with increasing amounts of p50 at 20, 30, and 37 °C.
B, p50 (11 pmol) was incubated as described in A
in the presence of varying concentrations of KCl at 30 °C.
C, 32P-labeled 58-nt RNA (0.5 pmol) and 69-nt
RNA (0.7 pmol) were incubated in the presence of the indicated
concentration of MgCl2 without and with p50 at 30 °C for
20 min. 5.5 pmol (D) or 11 pmol (E) of p50 was
incubated as described in A at 30 °C for the indicated
times. The positions of ss- and duplex-containing RNAs are shown. In
C, the longer exposure time reveals slowly migrating RNA
complexes.

View larger version (28K):
[in a new window]
Fig. 3.
p50 promotes renaturation of DNA
strands. A, schematic representation of the DNA
annealing assay. B, 32P-labeled 164-mer
heat-denatured DNA (35 fmol) was incubated in the presence of 5.5, 11, and 22 pmol of p50 (lanes 1-3) at 30 °C for 20 min.
C and D, 32P-labeled 164-mer
heat-denatured DNA was incubated in the presence of 22 pmol of p50
(C) or without p50 (D) for the indicated time.
The positions of heat-denatured and renatured DNA are indicated;
the stars mark the 32P-labeled strand.

View larger version (50K):
[in a new window]
Fig. 4.
p50 displays both RNA annealing and melting
activities in a dose-dependent manner. Upper
panel, predicted secondary structure of the 69-nt RNA. Lower
panel, 32P-1abeled 69-nt RNA (0.5 pmol), either native
(lanes 1-5) or heat-denatured (lanes 6-10) was
incubated with 2.8, 5.5, 11, and 22 pmol of p50 (lanes 2-5
and 7-10, respectively) at 30 °C for 20 min. Lanes
1 and 6, no p50 added. The positions of heat-denatured
and native RNAs are indicated.

View larger version (30K):
[in a new window]
Fig. 5.
p50 promotes RNA strand exchange.
Upper panel, schematic representation of the RNA strand
exchange assay. Lower panel, 97-nt ssRNA (0.5 pmol) was
incubated with the pre-formed 18-bp duplex-containing RNA (0.5 pmol) in
the presence of 0.35, 0.7, 1.4, 2.8, 5.5, 11, and 22 pmol of p50
(lanes 2-8, respectively) at 37 °C for 30 min.
Lane 1, no p50 added. The positions of the 18- and
46-bp duplex-containing RNAs prepared by hybridization in the absence
of p50 are indicated; the stars mark the
32P-1abeled strands.

View larger version (27K):
[in a new window]
Fig. 6.
The effect of p50 phosphorylation by casein
kinase II on RNA/DNA annealing efficiency. A,
32P-labeled 58-nt RNA (0.5 pmol) and 69-nt RNA (0.7 pmol)
possessing the 18-bp complementary region were incubated with
increasing amounts of either nonphosphorylated (lanes 1-3)
or phosphorylated p50 (lanes 4-6) at 30 °C for 20 min.
Lanes 1 and 4, 2.8 pmol; lanes 2 and
5, 5.5 pmol; lanes 3 and 6, 11 pmol of
p50 was added. The positions of ss- and duplex-containing RNAs are
indicated. B, 32P-labeled 164-mer heat-denatured
DNA (35 fmol) was incubated with increasing amounts of either
nonphosphorylated (lanes 1-3) or phosphorylated
(lanes 4-6) p50 at 30 °C for 20 min. Lanes 1 and 4, 5.5 pmol; lanes 2 and 5, 11 pmol; lanes 3 and 6, 22 pmol of p50 was added.
The positions of the heat-denatured and renatured DNA are
indicated.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed. Tel./Fax:
7-095-924-04-93; E-mail: ovchinn@vega.protres.ru.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Wool, I. G.
(1996)
Trends Biochem. Sci.
21,
164-165
2.
Siomi, H.,
and Dreyfuss, G.
(1997)
Curr. Opin. Genet. Dev.
7,
345-353
3.
Ladomery, M.
(1997)
BioEssays
19,
903-909
4.
Shyu, A. B.,
and Wilkinson, M. F.
(2000)
Cell
102,
135-138
5.
Wolffe, A. P.
(1994)
BioEssays
16,
245-251
6.
Spirin, A. S.
(1996)
in
Translational Control
(Hershey, J. W. B.
, Mathews, M. B.
, and Sonenberg, N., eds)
, pp. 319-334, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
7.
Sommerville, J.,
and Ladomery, M.
(1996)
Chromosoma
104,
469-478
8.
Evdokimova, V. M.,
and Ovchinnikov, L. P.
(1999)
Int. J. Biochem. Cell Biol.
31,
139-149
9.
Wolffe, A. P.,
Tafuri, S.,
Ranjan, M.,
and Familary, M.
(1992)
New Biol.
4,
290-298
10.
Sommerville, J.,
and Ladomery, M.
(1996)
FASEB J.
10,
435-443
11.
Evdokimova, V. M.,
Wei, C.-L.,
Sitikov, A. S.,
Simonenko, P. N.,
Lazarev, O. A.,
Vasilenko, K. S.,
Ustinov, V. A.,
Hershey, J. W. B.,
and Ovchinnikov, L. P.
(1995)
J. Biol. Chem.
270,
3186-3192
12.
Jiang, W.,
Hou, Y.,
and Inouye, M.
(1997)
J. Biol. Chem.
272,
196-202
13.
Swamynathan, S. K.,
Nambiar, A.,
and Guntaka, R. V.
(1998)
FASEB J.
12,
515-522
14.
Matsumoto, K.,
and Wolffe, A. P.
(1998)
Trends Cell Biol.
8,
318-323
15.
Sommerville, J.
(1999)
BioEssays
21,
319-325
16.
Blobel, G.
(1972)
Biochem. Biophys. Res. Commun.
47,
88-95
17.
Van Venrooij, W. J.,
Van Eekelen, C. A. G.,
Jansen, R. T. P.,
and Princen, J. M. G.
(1977)
Nature
270,
189-191
18.
Minich, W. B.,
Maidebura, I. P.,
and Ovchinnikov, L. P.
(1993)
Eur. J. Biochem.
212,
633-638
19.
Minich, W. B.,
and Ovchinnikov, L. P.
(1992)
Biochimie (Paris)
74,
477-483
20.
Minich, W. B.,
Volyanik, E. V.,
Korneyeva, N. L.,
Berezin, Y. V.,
and Ovchinnikov, L. P.
(1990)
Mol. Biol. Rep.
14,
65-67
21.
Davydova, E. K.,
Evdokimova, V. M.,
Ovchinnikov, L. P.,
and Hershey, J. W. B.
(1997)
Nucleic Acids Res.
25,
2911-2916
22.
Evdokimova, V. M.,
Kovrigina, E. A.,
Nashchekin, D. V.,
Davydova, E. K.,
Hershey, J. W. B.,
and Ovchinnikov, L. P.
(1998)
J. Biol. Chem.
273,
3574-3581
23.
Spirin, A. S.
(1994)
Mol. Reprod. Dev.
38,
107-117
24.
Ustinov, V. A.,
Skabkin, M. A.,
Nashchekin, D. V.,
Evdokimova, V. M.,
and Ovchinnikov, L. P.
(1996)
Biochemistry (Engl. Transl. Biokhimiya)
61,
414-419
25.
Pontius, B. W.,
and Berg, P.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
8403-8407
26.
Kumar, A.,
and Wilson, S. H.
(1990)
Biochemistry
29,
10717-10722
27.
Krainer, A. R.,
Conway, G. C.,
and Kozak, D.
(1990)
Genes Dev.
4,
1158-1171
28.
Lee, C. G.,
Zamore, P. D.,
Green, M. R.,
and Hurwitz, J.
(1993)
J. Biol. Chem.
268,
13472-13478
29.
Portman, D. S.,
and Dreyfuss, G.
(1994)
EMBO J.
13,
213-221
30.
Oberosler, P.,
Hloch, P.,
Ramsperger, U.,
and Stahl, H.
(1993)
EMBO J.
12,
2389-2396
31.
Bakalkin, G.,
Yakovleva, T.,
Selivanova, G.,
Magnusson, K. P.,
Szekely, L.,
Kiseleva, E.,
Klein, G.,
Terenius, L.,
and Wiman, K. G.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
413-417
32.
Tsuchihashi, Z.,
and Brown, P. O.
(1994)
J. Virol.
68,
5863-5870
33.
Kick, D.,
Barrett, P.,
Cummings, A.,
and Sommerville, J.
(1987)
Nucleic Acids Res.
15,
4099-4109
34.
Murray, M. T.,
Krohne, G.,
and Franke, W. W.
(1991)
J. Cell Biol.
112,
1-11
35.
Ohga, T.,
Koike, K.,
Ono, M.,
Makino, Y.,
Itagaki, Y.,
Tanimoto, M.,
Kuwano, M.,
and Kohno, K.
(1996)
Cancer Res.
56,
4224-4228
36.
Shibao, K.,
Takano, H.,
Nakayama, Y.,
Okazaki, K.,
Nagata, N.,
Izumi, H.,
Uchiumi, T.,
Kuwano, M.,
Kohno, K.,
and Itoh, H.
(1999)
Int. J. Cancer
83,
732-737
37.
Sabath, D. E.,
Podolin, P. L.,
Comber, P. G.,
and Prystowsky, M. B.
(1990)
J. Biol. Chem.
265,
12671-12678
38.
Grant, C. E.,
and Deeley, R. G.
(1993)
Mol. Cell. Biol.
13,
4186-4196
39.
Ito, K.,
Tsutsumi, K.,
Kuzumaki, T.,
Gomez, P.,
Otsu, K.,
and Ishikawa, K.
(1994)
Nucleic Acids Res.
22,
2036-2041
40.
Koike, K.,
Uchiumi, T.,
Ohga, T.,
Toh, S.,
Wada, M.,
Kohno, K.,
and Kuwano, M.
(1997)
FEBS Lett.
417,
390-394
41.
Ohga, T.,
Uchiumi, T.,
Makino, Y.,
Koike, K.,
Wada, M.,
Kuwano, M.,
and Kohno, K.
(1998)
J. Biol. Chem.
273,
5997-6000
42.
Graumann, P.,
and Marahiel, A.
(1996)
BioEssays
18,
309-315
43.
Manival, X.,
Ghisolfi-Nieto, L.,
Joseph, G.,
Bouvet, P.,
and Erard, M.
(2001)
Nucleic Acids Res.
29,
2223-2233
44.
Samarina, O. P.,
Lukanidin, E. M.,
Molnar, J.,
and Georgiev, G. P.
(1968)
J. Mol. Biol.
33,
251-263
45.
Herrick, G.,
and Alberts, B.
(1976)
J. Biol. Chem.
251,
2133-2141
46.
Karpel, R. L,
and Burchard, A. C.
(1980)
Biochemistry
19,
4674-4682
47.
Chansky, H. A.,
Hu, M.,
Hickstein, D. D.,
and Yang, L.
(2001)
Cancer Res.
61,
3586-3590
48.
Hasegawa, S. L.,
Doetsch, P. W.,
Hamilton, K. K.,
Martin, A. M.,
Okenquist, S. A.,
Lenz, J.,
and Boss, J. M.
(1991)
Nucleic Acids Res.
19,
4915-4920
49.
Gai, X. X.,
Lipson, K. E.,
and Prystowsky, M. B.
(1992)
Nucleic Acids Res.
20,
601-606
50.
MacDonald, G. H.,
Itoh-Lindstrom, Y.,
and Ting, J. P.-Y.
(1995)
J. Biol. Chem.
270,
3527-3533
51.
Bryant, F. R.,
and Lehman, I. R.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
297-301
52.
Norris, D.,
and Kolodner, R.
(1990)
Biochemistry
29,
7903-7911
53.
Sung, P.,
Prakash, L.,
and Prakash, S.
(1992)
Nature
355,
743-745
54.
Mortensen, U. H.,
Bendixen, C.,
Sunjevaric, I.,
and Rothstein, R.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10729-10734
55.
Rein, A.,
Henderson, L. E.,
and Levin, J. G.
(1998)
Trends Biochem. Sci.
23,
297-301
56.
Hitti, E.,
Neunteufl, A.,
and Jantsch, M. F.
(1998)
Nucleic Acids Res.
26,
4382-4388
57.
Herschlag, D.
(1995)
J. Biol. Chem.
270,
20871-20874
58.
Ghisolfi, L.,
Joseph, G.,
Amalric, F.,
and Erard, M.
(1992)
J. Biol. Chem.
267,
2955-2959
59.
Methot, N.,
Pause, A.,
Hershey, J. W. B.,
and Sonenberg, N.
(1994)
Mol. Cell. Biol.
14,
2307-2316
60.
Valcarcel, J.,
Gaur, R. K.,
Singh, R.,
and Green, M. R.
(1996)
Science
273,
1706-1709
61.
De Rocquigny, H.,
Gabus, C.,
Vincent, A.,
Fournie-Zaluski, M. C.,
Roques, B.,
and Darlix, J. L.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
6472-6476
62.
Lapadat-Tapolsky, M.,
Pernelle, C.,
Borie, C.,
and Darlix, J. L.
(1995)
Nucleic Acids Res.
23,
2434-2441
63.
Prats, A. C.,
Housset, V.,
de Billy, G.,
Cornille, F.,
Prats, H.,
Roques, B.,
and Darlix, J. L.
(1991)
Nucleic Acids Res.
19,
3533-3541
64.
De Rocquigny, H.,
Ficheux, D.,
Gabus, C.,
Allain, B.,
Fournie-Zaluski, M. C.,
Darlix, J. L.,
and Roques, B. P.
(1993)
Nucleic Acids Res.
21,
823-829
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. L. Ammerman, J. C. Fisk, and L. K. Read gRNA/pre-mRNA annealing and RNA chaperone activities of RBP16 RNA, June 1, 2008; 14(6): 1069 - 1080. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Miller, K. Halbig, J. Cruz-Reyes, and L. K. Read RBP16 stimulates trypanosome RNA editing in vitro at an early step in the editing reaction RNA, July 1, 2006; 12(7): 1292 - 1303. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Nashchekin, J. Zhao, N. Visa, and B. Daneholt A Novel Ded1-like RNA Helicase Interacts with the Y-box Protein ctYB-1 in Nuclear mRNP Particles and in Polysomes J. Biol. Chem., May 19, 2006; 281(20): 14263 - 14272. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Evdokimova, P. Ruzanov, M. S. Anglesio, A. V. Sorokin, L. P. Ovchinnikov, J. Buckley, T. J. Triche, N. Sonenberg, and P. H. B. Sorensen Akt-Mediated YB-1 Phosphorylation Activates Translation of Silent mRNA Species Mol. Cell. Biol., January 1, 2006; 26(1): 277 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yasen, K. Kajino, S. Kano, H. Tobita, J. Yamamoto, T. Uchiumi, S. Kon, M. Maeda, G. Obulhasim, S. Arii, et al. The Up-Regulation of Y-Box Binding Proteins (DNA Binding Protein A and Y-Box Binding Protein-1) as Prognostic Markers of Hepatocellular Carcinoma Clin. Cancer Res., October 15, 2005; 11(20): 7354 - 7361. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Matsumoto, K. J. Tanaka, and M. Tsujimoto An Acidic Protein, YBAP1, Mediates the Release of YB-1 from mRNA and Relieves the Translational Repression Activity of YB-1 Mol. Cell. Biol., March 1, 2005; 25(5): 1779 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takiya, Y. Nishita, S. Ishikawa, K. Ohno, T.-a. Tamura, and Y. Suzuki Bombyx Y-Box Protein BYB Facilitates Specific DNA Interaction of Various DNA Binding Proteins Independently of the Cold Shock Domain J. Biochem., June 1, 2004; 135(6): 683 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gabus, R. Mazroui, S. Tremblay, E. W. Khandjian, and J.-L. Darlix The fragile X mental retardation protein has nucleic acid chaperone properties Nucleic Acids Res., April 19, 2004; 32(7): 2129 - 2137. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fukuda, M. Ashizuka, T. Nakamura, K. Shibahara, K. Maeda, H. Izumi, K. Kohno, M. Kuwano, and T. Uchiumi Characterization of the 5'-untranslated region of YB-1 mRNA and autoregulation of translation by YB-1 protein Nucleic Acids Res., January 29, 2004; 32(2): 611 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Higashi, Y. Inagaki, K. Fujimori, A. Nakao, H. Kaneko, and I. Nakatsuka Interferon-{gamma} Interferes with Transforming Growth Factor-{beta} Signaling through Direct Interaction of YB-1 with Smad3 J. Biol. Chem., October 31, 2003; 278(44): 43470 - 43479. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Nekrasov, M. P. Ivshina, K. G. Chernov, E. A. Kovrigina, V. M. Evdokimova, A. A. M. Thomas, J. W. B. Hershey, and L. P. Ovchinnikov The mRNA-binding Protein YB-1 (p50) Prevents Association of the Eukaryotic Initiation Factor eIF4G with mRNA and Inhibits Protein Synthesis at the Initiation Stage J. Biol. Chem., April 11, 2003; 278(16): 13936 - 13943. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. PELLETIER and L. K. READ RBP16 is a multifunctional gene regulatory protein involved in editing and stabilization of specific mitochondrial mRNAs in Trypanosoma brucei RNA, April 1, 2003; 9(4): 457 - 468. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-S. Huang, W.-H. Su, J.-L. Wang, and H.-N. Wu Selective Strand Annealing and Selective Strand Exchange Promoted by the N-terminal Domain of Hepatitis Delta Antigen J. Biol. Chem., February 14, 2003; 278(8): 5685 - 5693. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Pisarev, M. A. Skabkin, A. A. Thomas, W. C. Merrick, L. P. Ovchinnikov, and I. N. Shatsky Positive and Negative Effects of the Major Mammalian Messenger Ribonucleoprotein p50 on Binding of 40 S Ribosomal Subunits to the Initiation Codon of beta -Globin mRNA J. Biol. Chem., May 3, 2002; 277(18): 15445 - 15451. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||